Shared Content Block:
Styles -- modify testimonial colors
The mission of the RNA Bioscience Initiative (RBI) is to cultivate a vibrant center of discovery and innovation in RNA biology, informatics, diagnostics, and therapy. Our goal is to provide a fluid pipeline from basic to clinical RNA research at the Anschutz Medical Campus.
May 5, 2021
Moderna recently announced that both its low-dose and variant-specific boosters effectively neutralize Covid-19 variants. Clinical trials of the boosters are ongoing; boosters are expected to be available in fall 2021.
April 14, 2021
With the success of their coronavirus vaccines, both Moderna and Pfizer are developing mRNA vaccines to fight influenza. mRNA-based flu vaccines offer several potential advantages over traditional flu vaccines, including better seasonal strain matching and generation of a stronger immune response.
February 8, 2021
Congratulations to former RBI Scholar, Katie Yergert, whose manuscript is featured as the cover piece for the current issue of Plos Biology. Katie was an RBI Scholar for the 2018-2019 year, and is currently working as a Postdoctoral Fellow in Dr. Gary Bassell's laboratory at Emory University.
January 1, 2021
Congratulations to Roberto Castro-Gutierrez, Raeann Goering, Divya Kolakada, Nicole Moss, and Matthew Szucs the RBI 2020-2021 RNA Scholars. These five graduate students were selected from a pool of 9 accomplished applicants. Each displays outstanding promise toward advancing RNA biology.
The RBI has made CU Anschutz a clear hub of RNA biology expertise, raising the status of the university and its researchers in the eyes of scientists at institutions around the country and the world. The RBI sets CU Anschutz up as a leader in the exciting and groundbreaking field of RNA biology.